B6Dnk;B6Brd;B6N-Tyrc-Brd Cyb561tm1a(EUCOMM)Wtsi/WtsiOulu

Status

Available to order

EMMA IDEM:05437
International strain nameB6Dnk;B6Brd;B6N-Tyrc-Brd Cyb561tm1a(EUCOMM)Wtsi/WtsiOulu
Alternative nameEPD0037_3_G01
Strain typeTargeted Mutant Strains
Allele/Transgene symbolCyb561tm1a(EUCOMM)Wtsi
Gene/Transgene symbolCyb561
DisclaimerPlease note that for EUCOMM and KOMP-CSD mice supplied to the scientific community by INFRAFRONTIER/EMMA:
  1. We can not guarantee a null mutation for Knock-out first alleles (tm1a alleles, see http://www.mousephenotype.org/about-ikmc/targeting-strategies) as the critical exon has not been deleted.
  2. That the structure of the targeted mutation in the ES cells obtained from EUCOMM/KOMP to generate EUCOMM/KOMP mice is not verified by INFRAFRONTIER/EMMA. It is recommended that the recipient confirms the mutation structure.
  3. No check for determining the copy number of the targeting construct in ES cells obtained from EUCOMM/KOMP is done by INFRAFRONTIER/EMMA.
  4. The level of quality control before mice are released is to confirm the individual mouse genotype by short range PCR.

Information from provider

Provider Wellcome Trust Sanger Institute
Provider affiliationWellcome Trust Sanger Institute
Genetic informationThis mouse line originates from EUCOMM ES clone EPD0037_3_G01. For further details on the construction of this clone see the page at the IMPC portal.
Phenotypic informationPotential phenotyping data in the IMPC portal
References
  • Genome-wide generation and systematic phenotyping of knockout mice reveals new roles for many genes.;White Jacqueline K, Gerdin Anna-Karin, Karp Natasha A, Ryder Ed, Buljan Marija, Bussell James N, Salisbury Jennifer, Clare Simon, Ingham Neil J, Podrini Christine, Houghton Richard, Estabel Jeanne, Bottomley Joanna R, Melvin David G, Sunter David, Adams Niels C, null null, Tannahill David, Logan Darren W, Macarthur Daniel G, Flint Jonathan, Mahajan Vinit B, Tsang Stephen H, Smyth Ian, Watt Fiona M, Skarnes William C, Dougan Gordon, Adams David J, Ramirez-Solis Ramiro, Bradley Allan, Steel Karen P, ;2013;Cell;154;452-64; 23870131

Information from EMMA

Archiving centreUniversity of Oulu, Oulu, Finland

Disease and phenotype information

IMPC phenotypes (allele matching)
  • decreased circulating calcium level / IMPC
  • abnormal response to new environment / IMPC
  • abnormal coat/hair pigmentation / IMPC
  • increased hematocrit / IMPC
  • abnormal bone mineralization / IMPC
  • decreased circulating chloride level / IMPC
  • increased erythrocyte cell number / IMPC
  • abnormal bone structure / IMPC
  • abnormal behavior / IMPC
  • decreased circulating serum albumin level / IMPC
  • increased hemoglobin content / IMPC
  • decreased circulating total protein level / IMPC
  • abnormal placement of pupils / IMPC
  • increased circulating amylase level / IMPC
  • increased circulating iron level / IMPC
  • increased circulating magnesium level / IMPC
IMPC phenotypes (gene matching)
  • abnormal response to new environment / IMPC
  • increased erythrocyte cell number / IMPC
  • decreased circulating total protein level / IMPC
  • decreased fasting circulating glucose level / IMPC
  • decreased lean body mass / IMPC
  • decreased circulating chloride level / IMPC
  • increased heart weight / IMPC
  • increased circulating aspartate transaminase level / IMPC
  • decreased bone mineral content / IMPC
  • abnormal head size / IMPC
  • increased total body fat amount / IMPC
  • abnormal bone structure / IMPC
  • abnormal behavior / IMPC
  • abnormal cranium morphology / IMPC
  • increased circulating iron level / IMPC
  • increased circulating amylase level / IMPC
  • narrow eye opening / IMPC
  • decreased circulating glucose level / IMPC
  • abnormal iris morphology / IMPC
  • tremors / IMPC
  • decreased exploration in new environment / IMPC
  • decreased circulating serum albumin level / IMPC
  • increased circulating alkaline phosphatase level / IMPC
  • decreased circulating calcium level / IMPC
  • abnormal tail length / IMPC
  • abnormal retina blood vessel morphology / IMPC
  • increased hematocrit / IMPC
  • abnormal gait / IMPC
  • increased circulating magnesium level / IMPC
  • abnormal placement of pupils / IMPC
  • abnormal coat/hair pigmentation / IMPC
  • abnormal maxilla morphology / IMPC
  • enlarged heart / IMPC
  • increased hemoglobin content / IMPC
  • increased circulating triglyceride level / IMPC
  • abnormal bone mineralization / IMPC
  • abnormal snout morphology / IMPC
MGI phenotypes (allele matching)
  • decreased circulating LDL cholesterol level / MGI
  • abnormal coat/hair pigmentation / MGI
  • increased hematocrit / MGI
  • increased erythrocyte cell number / MGI
  • abnormal behavior / MGI
  • increased hemoglobin content / MGI
  • increased circulating amylase level / MGI
  • increased circulating fructosamine level / MGI
  • increased circulating magnesium level / MGI
MGI phenotypes (gene matching)
  • decreased circulating LDL cholesterol level / MGI
  • abnormal coat/hair pigmentation / MGI
  • increased hematocrit / MGI
  • increased erythrocyte cell number / MGI
  • abnormal behavior / MGI
  • increased hemoglobin content / MGI
  • increased circulating amylase level / MGI
  • increased circulating fructosamine level / MGI
  • increased circulating magnesium level / MGI

Literature references

  • Genome-wide generation and systematic phenotyping of knockout mice reveals new roles for many genes.;White Jacqueline K, Gerdin Anna-Karin, Karp Natasha A, Ryder Ed, Buljan Marija, Bussell James N, Salisbury Jennifer, Clare Simon, Ingham Neil J, Podrini Christine, Houghton Richard, Estabel Jeanne, Bottomley Joanna R, Melvin David G, Sunter David, Adams Niels C, null null, Tannahill David, Logan Darren W, Macarthur Daniel G, Flint Jonathan, Mahajan Vinit B, Tsang Stephen H, Smyth Ian, Watt Fiona M, Skarnes William C, Dougan Gordon, Adams David J, Ramirez-Solis Ramiro, Bradley Allan, Steel Karen P, ;2013;Cell;154;452-64; 23870131

Information on how we integrate external resources can be found here

Order

Availabilities

Requesting frozen sperm or embryos is generally advisable wherever possible, in order to minimise the shipment of live mice.

Due to the dynamic nature of our processes strain availability may change at short notice. The local repository manager will advise you in these circumstances.

* In addition users have to cover all the shipping costs (including the cost for returning dry-shippers, where applicable).

More details on pricing and delivery times

Practical information

Genotyping protocol

Example health report
(Current health report will be provided later)

Material Transfer Agreement (MTA)
Distribution of this strain is subject to a provider MTA. Both signing of the MTA and submission of the online EMMA Mutant Request Form are required before material can be shipped.

EMMA conditions
Legally binding conditions for the transfer

Other EMMA strains

Not found what you were looking for? Search here for other strains available from EMMA.


Search
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).